Sign In
U.S. Department of Health & Human Services
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Products Purchased by the US Government
Bamlanivimab
Bamlanivimab-etesevimab
Bamlanivimab/etesevimab Emergency Use Authorization | HHS/ASPR
Bebtelovimab
Bebtelovimab Frequently Asked Questions | HHS/ASPR
Bebtelovimab Emergency Use Authorization | HHS/ASPR
related-resources
Evusheld
Evusheld Emergency Use Authorization | HHS/ASPR
Evusheld Frequently Asked Questions | HHS/ASPR
Lagevrio
Lagevrio (molnupiravir) Frequently Asked Questions | HHS/ASPR
Lagevrio (molnupiravir) Emergency Use Authorization | HHS/ASPR
Molnupiravir
Lagevrio | HHS/ASPR
Lagevrio (molnupiravir) Emergency Use Authorization | HHS/ASPR
Lagevrio (molnupiravir) Frequently Asked Questions | HHS/ASPR
Lagevrio (molnupiravir) Emergency Use Authorization | HHS/ASPR
Lagevrio | HHS/ASPR
Paxlovid
Paxlovid Emergency Use Authorization | HHS/ASPR
Paxlovid Frequently Asked Questions | HHS/ASPR
REGEN-COV
REGEN-COV Emergency Use Authorization | HHS/ASPR
Sotrovimab
Sotrovimab Emergency Use Authorization | HHS/ASPR
Veklury
COVID-19 Product Resources | HHS/ASPR
Currently selected
Toggle navigation
About ASPR
Overview
Mission and Key Priorities
Program Offices
Organization Chart
Budget and Funding
Leadership Biographies
ASPR Year in Review
Working with ASPR
Newsroom
Blog
Response Operations
Health Care Readiness
Medical Countermeasures and Biodefense
Tools
COVID-19
COVID-19 Therapeutic Product Resources
General Resources
Federal Response to COVID-19: Therapeutics Clinical Implementation Guide
Read about an overview of the therapeutics, when to use them, their authorizations, and administration guidelines.
Test to Treat
Faster, easier access to life-saving COVID-19 treatments
Locating Sites For COVID-19 Treatments
Use these resources to identify sites of care administering COVID-19 therapies.
CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
Find scientific review documents about each of the therapeutic products.
FDA Emergency Use Authorizations
Read about the current COVID-19 Emergency Use Authorizations.
Federal Retail Pharmacy Therapeutics Program (FRPTP)
Learn about the FRPTP program and how it increases COVID-19 therapeutics access and equity across the country.
COVID-19 Therapeutics Shelf-life Extensions
View the current shelf-life extensions for COVID-19 therapeutic products.
Monoclonal Antibody (mAb) Resources
Centers for Medicare and Medicaid Services COVID-19 mAb Information
View a list of the mAb therapies and the updated EUA standings for each therapy.
Anti-SARS-CoV-2 Monoclonal Antibodies
Discover drug information and clinical data about the mAbs.
Frequently Asked Questions Provided by ASPR
Test to Treat
mAb State/Territory-Coordinated Distribution System
Bebtelovimab
Evusheld
Paxlovid
Lagevrio (molnupiravir)
Evusheld
Evusheld
Visit the Evusheld webpage to view current information and updates about the therapeutic product.
Evusheld EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
ASPR Evusheld FAQ
Find the answers to some frequently asked questions provided by ASPR.
Paxlovid
Paxlovid
Visit the Paxlovid webpage to view current information and updates about the therapeutic product.
Paxlovid EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
ASPR Paxlovid FAQ
Find the answers to some frequently asked questions provided by ASPR.
Paxlovid Drug Interaction Checker
Use this interactive tool to identify any drug interactions with Paxlovid.
Lagevrio (molnupiravir)
Lagevrio
Visit the Lagevrio webpage to view current information and updates about the therapeutic product.
Lagevrio EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
ASPR Lagevrio FAQ
Find the answers to some frequently asked questions provided by ASPR.
Bebtelovimab
Bebtelovimab
Visit the Bebtelovimab webpage to view current information and updates about the therapeutic product.
Bebtelovimab EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
ASPR Bebtelovimab FAQ
Find the answers to some frequently asked questions provided by ASPR.
REGEN-COV
REGEN-COV
Visit the REGEN-COV webpage to view current information and updates about the therapeutic product.
REGEN-COV EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
Resources for Healthcare Providers (Regeneron)
January 24, 2022, fact sheet provided by Regeneron about REGEN-COV.
Important Prescribing Information
A letter from Regeneron to healthcare providers on preventing medication errors.
Early Distribution of REGEN-COV by Jurisdiction
See where REGEN-COV was distributed by state and territory from November 24, 2020, to February 2, 2021.
Bamlanivimab/Etesevimab
Bamlanivimab/Etesevimab
Visit the Bamlanivimab/Etesevimab webpage to view current information and updates about the therapeutic product.
Bamlanivimab/Etesevimab EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
Sotrovimab
Sotrovimab
Visit the Sotrovimab webpage to view current information and updates about the therapeutic product.
Sotrovimab EUA Resources
Read the FDA resources and healthcare and patient fact sheets.
COVID-19 Therapeutics Right-Nav
COVID-19 Therapeutics
Locating COVID-19 Therapeutics
Test to Treat
COVID-19 Therapeutics Locator for Providers
COVID-19 Therapeutics Thresholds by Jurisdiction
Product Resources
Product Resources
Therapeutics Clinical Implementation Guide
COVID-19 Therapeutics Decision Aid
Side-by-Side Outpatient Therapeutics Overview
COVID‑19 Outpatient Therapeutics Videos and Resources
Products Purchased by the U.S. Government
Bebtelovimab
Evusheld
Lagevrio (molnupiravir)
Paxlovid
Sotrovimab
REGEN-COV
Bamlanivimab/etesevimab
Bamlanivimab
Announcements
Important Updates
Social Media Digital Toolkit